Prudence Dorazio
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 2
- Peptidase Inhibition and Analysis 1
-
- Pneumonia and Respiratory Infections 1
- Co-authors
- Jesús Gómez-Navarro (2 shared papers)Diane Healey (3 shared papers)Bo Huang (1 shared paper)Ira Gore (2 shared papers)Alan P. Venook (2 shared papers)Leonard B. Saltz (2 shared papers)Lawrence Fong (2 shared papers)Ki Y. Chung (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)PubMed (2 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Prudence Dorazio
7 papers receiving 498 citations
Peers
Comparison fields: 5 of 31
- Oncology 429
- Immunology 280
- Pathology and Forensic Medicine 50
- Microbiology 17
- Cancer Research 31
Countries citing papers authored by Prudence Dorazio
This map shows the geographic impact of Prudence Dorazio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence Dorazio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence Dorazio more than expected).
Fields of papers citing papers by Prudence Dorazio
This network shows the impact of papers produced by Prudence Dorazio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence Dorazio. The network helps show where Prudence Dorazio may publish in the future.
Co-authors
The 25 scholars most cited alongside Prudence Dorazio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 239 | |
| 2 | 2010 | 238 | |
| 3 | Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines. | 1997 | 11 |
| 4 | 2008 | 8 | |
| 5 | 2007 | 6 | |
| 6 | Characterization of Bordetella pertussis strains of recent isolation. | 1999 | 6 |
| 7 | 2009 | 3 |
About Prudence Dorazio
Prudence Dorazio is a scholar working on Oncology, Epidemiology, Microbiology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 7 papers that have together received 511 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Bacterial Infections and Vaccines (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Genomics and Diagnostics (1 paper), Inflammatory mediators and NSAID effects (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Peptidase Inhibition and Analysis (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Oncology (429 citations), Immunology (280 citations), Pathology and Forensic Medicine (50 citations), Microbiology (17 citations) and Cancer Research (31 citations). Prudence Dorazio has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Jesús Gómez-Navarro, Diane Healey, Bo Huang, Ira Gore, Alan P. Venook, Leonard B. Saltz, Lawrence Fong, Ki Y. Chung, Patricia LoRusso and Tiziana Usari. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.